Zusammenfassung
Patienten mit „medizinisch unerklärten Körpersymptomen“ stellen im medizinischen Versorgungssystem eine diagnostische und therapeutische Herausforderung dar. Eine psychiatrische Perspektive betont diagnostisch primäre psychische Störungen einerseits, somatoforme Störungen andererseits. In der klinisch-somatischen Medizin existiert eine eigenständige diagnostische Beschreibung von fachbezogen definierten funktionellen Körpersyndromen. Beide diagnostischen Systeme sind nicht deckungsgleich. Kritikpunkte an der derzeitigen Konzeptualisierung und Klassifikation von somatoformen Störungen werden dargestellt. Die in den aktuellen psychiatrischen Klassifikationssystemen aufgeführten somatoformen Störungen werden in ihren klinischen Charakteristika skizziert. Somatoforme Störungen werden ätiopathogenetisch vorteilhaft innerhalb eines multifaktoriellen Modells beschrieben, in dem psychosoziale und neurobiologische Einflüsse eigenständig bewertet werden müssen. Es lassen sich formale Behandlungsziele und allgemeine Behandlungsprinzipien beschreiben. Psychoedukative, psychopharmakologische, kognitiv-behaviorale, psychodynamische und rehabilitative Ansätze begründen eine multimodale Therapie der somatoformen Störungen. Das Management in der primärärztlichen Versorgung verdient eine besondere Beachtung.
Summary
Patients presenting with bodily symptoms and complaints that are not explained by organic pathology or well-known pathophysiological mechanisms comprise a major challenge to any medical care system. From a perspective of psychiatric classification, such medically unexplained somatic symptoms are diagnosed as depressive and anxiety disorders on the one hand or somatoform disorders on the other. In clinical physical medicine a quite different diagnostic approach is taken to conceptualize functional somatic syndromes. Concepts of somatoform disorders are outlined, critical issues regarding existing diagnostic systems are discussed, and possible alternative approaches for upcoming versions of DSM-V and ICD-11 are mentioned. The main somatoform disorders are described in their clinical characteristics. Etiopathogenetically, somatoform disorders may best be considered within a multifactorial model. Some pragmatic guidelines for multimodal treatment of somatoform disorders are outlined.
Literatur
Bass C (2006) Rehabilitation in patients with psychogenic movement disorders. In: Hallett M, Fahn S, Jankovic J, Lang AE et al. (eds) Psychogenic movement disorders. Neurology and Neuropsychiatry. Neurology Reference Series. American Academy of Neurology Press. Lippincott Williams & Wilkins, Philadelphia, pp 311–318
Egle UT, Nickel R (2006) Psychodynamische Behandlung somatoformer Störungen. In: Möller HJ (Hrsg) Therapie psychischer Erkrankungen. 3. Aufl. Thieme, Stuttgart, S 930–938
Fava GA, Fabbri S, Sirri L, Wise TN (2007) Psychological factors medical condition: A new proposal for DSM-V. Psychosomatics 48: 103–111
Fava GA, Wise TN (2007) Issues for DSM-V: Psychological factors affecting either identified or feared medical conditions: A solution for somatoform disorders. Am J Psychiatry 164: 1002–1003
Fink P, Rosendal M, Olesen F (2005) Classification of somatization and functional somatic symptoms in primary care. Aust N Z J Psychiatry 39: 772–781
Fink P, Rosendal M, Toft T (2002) Assessment and treatment of functional disorders in general practice: The extended reattribution and management model – an advanced educational program for nonpsychiatric doctors. Psychosomatics 43: 93–131
Gündel H, Siess M, Ehlert U (2001) Psychoedukative Schmerzbewältigungsprogramme zur Förderung der weiteren Psychotherapieakzeptanz. In: Kapfhammer HP, Gündel H (Hrsg) Psychotherapie der Somatisierungsstörungen. Thieme, Stuttgart, S 252–259
Henningsen P, Hartkamp N, Loew T et al. (2002) Somatoforme Störungen. Leitlinien und Quellentexte. Schattauer, Stuttgart
Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Invited review. Lancet 369: 946–955
Hiller W, Rief W (2005) Why DSM-III was right to introduce the concept of somatoform disorders. Psychosomatics 46: 105–108
Jackson JL, O‘Malley PG, Kroenke K (2006) Antidepressants and cognitive-behavioral therapy for somatic syndromes. CNS Spectr 11: 212–222
Janca A (2005) Rethinking somatoform disorders. Curr Opin Psychiatry 18: 65–71
Kapfhammer HP (2004) Behandlungsprobleme bei somatoformen Störungen. In: Rössler W (Hrsg) Psychiatrische Rehabilitation. Springer, Berlin Heidelberg New York Tokyo, S 594–608
Kapfhammer HP (2007) Konzept, ätiologische Perspektive und Diagnostik somatoformer Störungen. Psychosom Konsiliarpsychiatr 1: 87–98
Kapfhammer HP (2008) Somatoforme Störungen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. 3. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 767–902
Kapfhammer HP (2008) Dissoziative Störungen. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. 3. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 723–765
Kapfhammer HP (2008) Pharmakotherapie somatoformer Störungen. In: Benkert O, Gründer Holsboer F (Hrsg) Handbuch der Psychopharmakotherapie. Springer, Berlin Heidelberg New York Tokyo, S 949–962
Kroenke K (2006) Physical symptom disorder: A simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60: 335–339
Kroenke K, Rosmalen JGM (2006) Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 90: 603–626
Kroenke K, Sharpe M, Sykes R (2007) Revising the classification of somatoform disorders: Key questions and preliminary recommendations. Psychosomatics 48: 277–285
Kroenke K, Swindle R (2000) Cognitive-behavioral therapy for somatization and somatization syndromes: A critical review of controlled clinical trials. Psychother Psychosom 69: 205–215
Leichsenring F, Rabung S, Leibing E (2004) The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 61: 1208–1216
Mayou R, Kirmayer LJ, Simon G et al. (2005) Somatoform disorders: Time for a new approach in DSM-IV. Am J Psychiatry 162: 847–855
Page L, Wessely S (2007) Functional somatic syndromes. In: Lloyd GG, Guthrie E (eds) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, pp 125–148
Raine R, Haines A, Sensky T et al. (2002) Systematic review of mental health interventions for patients with common somatic symptoms: Can research evidence from secondary care be extrapolated to primary care? BMJ 325: 1082–1093
Rief W (1995) Multiple somatoforme Symptome und Hypochondrie. Empirische Beiträge zur Diagnostik und Behandlung. Huber, Bern Göttingen Toronto Seattle
Rief W, Henningsen P, Hiller W (2006) Classification of somatoform disorders. Am J Psychiatry 746–747
Rief W, Sharpe M (2004) Somatoform disorders – new approaches to classification, conzeptualization, and treatment. J Psychosom Res 56: 387–390
Rost KM, Kashner MT, Smith GR (1994) Effectiveness of psychiatric intervention with somatization disorder patients: Improved outcomes at reduced costs. Gen Hosp Psychiatry 16: 381–387
Salmon P, Humphris GM, Ring A et al. (2006) Why do primary care physicians propose medical care to patients with medically unexplained symptoms? A new method of sequence analysis to test theories of patient pressure. Psychosom Med 68: 570–577
Smith GR, Monson RA, Ray DC (1986) Psychiatric consultation in somatization disorder: A randomized controlled study. N Engl J Med 314: 1407–1413
Starcevic V (2006) Somatoform disorders and DSM-V: Conceptual and political issues in the debate. Psychosomatics 47: 277–281
Tazaki M, Landlaw K (2006) Behavioural mechanisms and cognitive-behavioural interventions of somatoform disorders. Int Rev Psychiatry 18: 67–73
Van der Feltz-Cornelis CM, Oppen P van, Ader HJ, Dyck R van (2006) Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 75: 282–289
World Health Organisation (1999) ICDH-2 International classification of functioning and disability. Beta-2 draft, full version. WHO, Genf
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapfhammer, H. Somatoforme Störungen. Nervenarzt 79, 99–117 (2008). https://doi.org/10.1007/s00115-007-2388-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-007-2388-8